Login / Signup

Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension.

Sandeep SainathanJohn RyanLeonardo MullinariPablo G Sanchez
Published in: Clinical transplantation (2023)
Patients undergoing LT for PVOD had better initial survival, which disappeared after 1 year of transplantation. Donation after circulatory death donor use had a short-term survival disadvantage.
Keyphrases
  • pulmonary arterial hypertension
  • pulmonary hypertension
  • patients undergoing
  • pulmonary artery
  • extracorporeal membrane oxygenation
  • blood pressure
  • stem cells
  • cell therapy
  • bone marrow